Literature DB >> 14954737

[Additional investigations in experimental chemotherapy of tuberculosis (neoteban)].

G DOMAGK, H A OFFE, W SIEFKEN.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/derivatives; TUBERCULOSIS/experimental

Mesh:

Substances:

Year:  1952        PMID: 14954737     DOI: 10.1055/s-0028-1116024

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  9 in total

1.  [Tuberculostatics and resistance studies on the reduction of sensitivity of tubercle bacteria].

Authors:  J RICHTER
Journal:  Z Hyg Infektionskr       Date:  1954

2.  [Synergistic effect of isonicotinic acid hydrazide and sulfonamide; in vitro studies].

Authors:  G GILLISSEN
Journal:  Z Hyg Infektionskr       Date:  1954

3.  [Bacteriological findings with neoteben].

Authors:  K LIEBERMEISTER
Journal:  Z Hyg Infektionskr       Date:  1953

4.  [Effective tuberculostatic minimal concentration of streptomycin, conteben, PAS and neoteben in vitro and resistance phenomenon].

Authors:  S WEIDMANN; H SAAME
Journal:  Z Hyg Infektionskr       Date:  1953

5.  [The distribution of isonicotinic acid hydrazide in man].

Authors:  H JUNGBLUTH; F LEUSCHNER; K L RADENBACH
Journal:  Klin Wochenschr       Date:  1953-06-01

6.  Isoniazid in childhood tuberculosis.

Authors:  G BOYD; T E ROY; A JOSIUKAS
Journal:  Can Med Assoc J       Date:  1953-09       Impact factor: 8.262

7.  [Quantitative microbiologic index of isonicotinic acid hydrazide in serum, spinal fluid and urine].

Authors:  F J GEKS
Journal:  Klin Wochenschr       Date:  1952-11-15

Review 8.  The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis.

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  J Mol Biol       Date:  2019-02-21       Impact factor: 5.469

9.  [Experimental investigations on liver damage by Rimifon (isonicotinic acid hydrazide)].

Authors:  R EMMRICH; H PETZOLD
Journal:  Klin Wochenschr       Date:  1952-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.